Canada’s governing Liberal Party will announce the country’s new prime minister March 9 after a leadership vote that follows the resignation of Justin Trudeau this week. The party’s National Board ...
Benin's military says that militants inflicted heavy losses on the country's armed forces during an attack this week on a fortified military post in the north. Col. Faizou Gomina, the ...
Walgreens booked a better-than-expected fiscal first quarter, but the drugstore chain lost $265 million as it closed U.S. stores and continued work to revive its business. The company has been ...
The Lewisburg Area School District school board on Thursday accepted a $19,400 bid from Buffalo Valley Fence Supply for new ...
Today in Sports - After 24 seasons and 6 Super Bowls, Bill Belichick and the Patriots part ways; China Automotive Multimodal Interaction Development Research Report 2024: AI Found ...
Tractor Supply Company (NASDAQ: TSCO ), the largest rural lifestyle retailer in the United States, in partnership with three-time GRAMMY winner Miranda Lambert’s MuttNation Foundation, announced today ...
IQHQ, Inc. (“IQHQ” or “the Company”), a premier owner and developer of world-class life science districts, today announced ...
SEATTLE (AP) — SEATTLE (AP) — Accolade, Inc. (ACCD) on Friday reported a loss of $121.3 million in its fiscal third quarter. On a per-share basis, the Seattle-based company said it had a loss of $1.50 ...
WASHINGTON (AP) — U.S. economy added a strong 256,000 jobs in December and the unemployment rate dipped to 4.1%. Copyright 2025 The Associated Press. All rights reserved. This material may not be ...
Constellation will acquire power company Calpine for $16.4 billion, linking two of the nation's biggest power companies.
The law that could ban TikTok is coming before the Supreme Court. The justices largely hold the app’s fate in their hands as they hear the case Friday. The popular ...
The overall safety profile of sasanlimab in combination with BCG was generally consistent with the known profile of BCG and data reported from clinical trials with sasanlimab. The profile of ...